Prosecution Insights
Last updated: August 17, 2026
Application No. 18/950,289

PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS

Non-Final OA §102§103
Filed
Nov 18, 2024
Examiner
DEAK, LESLIE R
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
The Procter & Gamble Company
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
1y 6m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
715 granted / 948 resolved
+5.4% vs TC avg
Strong +18% interview lift
Without
With
+17.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
37 currently pending
Career history
988
Total Applications
across all art units

Statute-Specific Performance

§101
2.4%
-37.6% vs TC avg
§103
50.1%
+10.1% vs TC avg
§102
22.6%
-17.4% vs TC avg
§112
11.3%
-28.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 948 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-4, 6-9, 13 are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by US 2020/0229992 to Agami et al. In the specification and figures, Agami discloses the apparatus as claimed by Applicant. With regard to claims 1, 3, Agami discloses a feminine hygiene article comprising a folded pad 10 wherein the pad comprises a topsheet 20, a backsheet 30, and an absorbent structure 40 therebetween, wherein the pad may be disposed within a package 50 with adhesive 35 deposited in a discontinuous fashion between the folded pad and the package to adhere to both the pad and a removable coversheet 17 (see FIGS 1, 2A, ¶0039, ¶0078-87, 0107). With regard to claims 2 and 9, Applicant is setting forth the intended use of the claimed apparatus. It has been held that a recitation with respect to the manner in which a claimed apparatus is intended to be employed does not differentiate the claimed apparatus from a prior art apparatus satisfying the claimed structural limitations. See MPEP § 2114. With regard to claim 4, Agami discloses that backsheet adhesive may be applied to the backsheet 30 or the coversheet 17 such that the adhesive applied to the backsheet coversheets allow the user to peel the pad from the coversheet (see ¶0107). With regard to claims 6-8 and 13, the envelope package 50 and the coversheet 17 may comprise polymeric film materials, wherein the package may comprise additives, while the coversheet does not, thereby comprising different polymers and basis weights (see ¶0089-0090, 0108). Claims 1-5, 9-10 are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by WO 2024/196633 to Maldonado et al. In the specification and figures, Maldonado discloses the apparatus as claimed by Applicant. With regard to claims 1 and 3, Maldonado discloses a folded individual feminine hygiene pad 20 with a topsheet 30, backsheet 40, and an absorbent core 50, the pad being disposed within a package 80, and an adhesive 70 disposed in a discontinuos fashion between the pad 20 and the package 80 (see FIGS 1, 2, p2, ln 5-30, p9, ln 4-23). With regard to claims 2 and 9, Applicant is setting forth the intended use of the claimed apparatus. It has been held that a recitation with respect to the manner in which a claimed apparatus is intended to be employed does not differentiate the claimed apparatus from a prior art apparatus satisfying the claimed structural limitations. See MPEP § 2114. With regard to claims 4-5, Maldonado discloses that the adhesive 70 may be covered by a release film or paper that is adhered to the wrapper 80 (see p9, ln 24-32, p15, ln 5-17). With regard to claim 10, Maldonado discloses that the product may use hot-melt adhesives (see p 19, ln 5-21). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 11, 12, 14 are rejected under 35 U.S.C. 103 as being unpatentable over US 2020/0229992 to Agami et al. In the specification and figures, Agami discloses the apparatus substantially as claimed by Applicant (see rejections above). With regard to claims 11 and 12, Agami discloses that the apparatus comprises thermal bonds, especially wherein the discontinuous bonds of the envelope create an embossed pattern (see ¶0089). With regard to claim 14, Agami illustrates an envelope 50 with a flap 58 and an adhesive 60a on the underside of the flap, suggesting that a weight of adhesive is disposed on an inward-facing side of the flap (see FIG 5A). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LESLIE R DEAK whose telephone number is (571)272-4943. The examiner can normally be reached Monday-Friday, 9am to 5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at 571-272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LESLIE R DEAK/Primary Examiner, Art Unit 3799 16 July 2026
Read full office action

Prosecution Timeline

Nov 18, 2024
Application Filed
Jul 20, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12697421
INTEGRATED AUTOTRANSFUSION BOWL AND FLUID LINE ORGANIZER
2y 6m to grant Granted Aug 04, 2026
Patent 12691266
FLEXIBLE SHUNT IMPLANTS
3y 1m to grant Granted Jul 28, 2026
Patent 12678550
NEW STANDARDIZATIONS & MEDICAL DEVICES FOR THE PREPARATION OF PLATELET RICH PLASMA (PRP) OR BONE MARROW CONCENTRATE (BMC) ALONE OR IN COMBINATION WITH HYALURONIC ACID
5y 0m to grant Granted Jul 14, 2026
Patent 12678328
INTRAOCULAR SHUNTS WITH LOW-PROFILE ACTUATION ELEMENTS AND ASSOCIATED SYSTEMS AND METHODS
3y 4m to grant Granted Jul 14, 2026
Patent 12667488
SHUNTING SYSTEMS WITH ROTATION-BASED FLOW CONTROL ASSEMBLIES, AND ASSOCIATED SYSTEMS AND METHODS
3y 2m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
93%
With Interview (+17.5%)
3y 3m (~1y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 948 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month